Loading...
Loading...
Among the 2 tracked institutional investors we monitor, SGP (SPYGLASS PHARMA INC) is held with a combined value of $4.20M across 161,989 shares. The largest holder is BlackRock, Inc. with a position worth $3.75M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter.
Total Institutional Value
$4.20M
Total Shares Held
161,989
Institutional Holders
2
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $3.75M | 0.00% | New |
| 2 | STATE STREET CORP | $446.95K | 0.00% | New |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of SGP with a position worth $3.75M, representing 0.00% of their portfolio. In total, 2 institutional investors hold SGP with a combined value of $4.20M.
In the most recent quarter, 2 funds opened a new position in SGP.
Institutional investors hold $4.20M worth of SGP stock across 2 positions. The largest institutional holder is BlackRock, Inc. with $3.75M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SGP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SGP positions.